文献情報

当社製品に関連した文献情報を掲載しております

Myco Finder

Detection of Mycoplasma Contamination in Transplanted Retinal Cells by Rapid and Sensitive Polymerase Chain Reaction Test. Sunao Sugita., et al. Int. J. Mol. Sci. 2021, 22, https://doi.org/10.3390/ijms222212555

マイコプラズマ否定試験に用いるマイコプラズマ参照品に関する研究(第2 報) 第十七改正日本薬局方収載NBRC 由来マイコプラズマの核酸増幅法(NAT)による検出感度に関する共同比較研究. 湯之前 雄太 他, Pharmaceutical and Medical Device Regulatory Science Vol. 51, No. 4, 224 ~ 233(2020)

NS-A2

Long-term eradication of extranodal natural killer/T-cell lymphoma, nasal type, by induced pluripotent stem cell-derived Epstein-Barr virus-specific rejuvenated T cells in vivo. Miki Ando., et al. Haematologica 2020 Volume 105(3):796-807 https://doi.org/10.3324/haematol.2019.223511

Dual-antigen targeted iPSC-derived chimeric antigen receptor-T cell therapy for refractory lymphoma. Sakiko Harada., et al. Molecular therapy Vol. 30 No 2: 534-549 https://doi.org/10.1016/j.ymthe.2021.10.006

iPSC-derived hypoimmunogenic tissue resident memory T cells mediate robust anti-tumor activity against cervical cancer. Yoshiki Furukawa., et al. Cell Rep Med. 2023 Dec 8:101327. https://doi.org/10.1016/j.xcrm.2023.101327.

DCO-K

Interferon-α-Induced Dendritic Cells Generated with Human Platelet Lysate Exhibit Elevated Antigen Presenting Ability to Cytotoxic T Lymphocytes. Ippei Date., et al. Vaccines 2021,9(1), 10 https://dx.doi.org/10.3390/vaccines9010010

Clinical Trial on the Safety and Tolerability of Personalized Cancer Vaccines Using Human Platelet Lysate-Induced Antigen-Presenting Cells. Terutsugu Koya., et al. Cancers 2023, 15, 3627. https://doi.org/10.3390/cancers15143627